| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/06/1992 | WO1992013078A2 Pasteurella haemolytica glycoprotease gene and the purified enzyme |
| 08/06/1992 | WO1992013077A1 A cDNA ENCODING THE TYPE I IODOTHYRONINE 5' DEIODINASE |
| 08/06/1992 | WO1992013075A1 Megakaryocyte stimulating factors |
| 08/06/1992 | WO1992013074A1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
| 08/06/1992 | WO1992013073A1 Pdgf-b analogues |
| 08/06/1992 | WO1992013072A2 Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli |
| 08/06/1992 | WO1992013069A1 Test and model for alzheimer's disease |
| 08/06/1992 | WO1992013063A1 Methods of transcriptionally modulating expression of growth factor genes and growth factor receptor genes |
| 08/06/1992 | WO1992013003A1 Macroscopically oriented cell adhesion protein for wound treatment |
| 08/06/1992 | WO1992013002A1 Influenza virus vaccine composition having a synergistic effect and containing influenza virus core as an additive |
| 08/06/1992 | WO1992013001A1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS |
| 08/06/1992 | WO1992013000A1 Novel thyroid antigen |
| 08/06/1992 | WO1992012997A1 Human galanin |
| 08/06/1992 | WO1992012996A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | WO1992012994A1 Mixed specificity fusion proteins |
| 08/06/1992 | WO1992012992A2 Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods |
| 08/06/1992 | WO1992012731A1 Glycosylated gag antigens and antibodies which react with live cells expressing those antigens |
| 08/06/1992 | WO1992012726A1 Use of interleukin-10 in adoptive immunotherapy of cancer |
| 08/06/1992 | WO1992012725A1 Treatment of neoplastic disease with interleukin-10 |
| 08/06/1992 | WO1992012635A1 Methods of transcriptionally modulating gene expression of viral genes and other genes |
| 08/06/1992 | WO1992008740A3 Receptor recognition factor and methods of use thereof |
| 08/06/1992 | CA2372251A1 Test and model for alzheimer's disease |
| 08/06/1992 | CA2101781A1 Pasteurella haemolytica glycoprotease gene and the purified enzyme |
| 08/06/1992 | CA2101065A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | CA2100553A1 Treatment of neoplastic disease with interleukin-10 |
| 08/06/1992 | CA2100068A1 Trans-splicing ribozymes |
| 08/06/1992 | CA2097424A1 Corticotropin releasing factor binding protein (crf-bp) |
| 08/05/1992 | WO1992013877A1 Factor iia inhibitors |
| 08/05/1992 | WO1992013865A1 Pmn-derived cr3 modulator and uses thereof |
| 08/05/1992 | EP0497585A2 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 08/05/1992 | EP0497525A2 Pneumococcal polysaccharide conjugate vaccine |
| 08/05/1992 | EP0497368A1 CNP analog peptides and their use |
| 08/05/1992 | EP0497366A2 Antimicrobial peptides and their use against plant pathogens |
| 08/05/1992 | EP0496973A2 Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations |
| 08/05/1992 | EP0496875A1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 08/05/1992 | EP0496833A1 BIOSYNTHETIC CONSTRUCTS OF TGF-$g(b) |
| 08/05/1992 | EP0496818A1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR |
| 08/05/1992 | EP0496814A1 Novel expression systems utilizing bacteriophage t7 promoters and gene sequences |
| 08/05/1992 | EP0496794A1 Non-infectious hiv-1 particles and uses therefor |
| 08/05/1992 | EP0496777A1 Dna, constructs, cells and plants derived therefrom |
| 08/05/1992 | EP0478696A4 Efficient method for identifiable expression of non-selectable genes |
| 08/05/1992 | EP0437579A4 Enhancement of naphthalene dioxygenase activity during microbial indigo production |
| 08/05/1992 | EP0217919B1 Type-specific papillomavirus dna sequences and peptides |
| 08/05/1992 | EP0185076B1 Hybrid protein |
| 08/05/1992 | CN1063308A Use of interleukin-10 in adoptive immunotherapy of cancer |
| 08/05/1992 | CN1017722B Process for preparation of strains of bacillus thuringiensis having improved activity against certain lepidopterous pests |
| 08/05/1992 | CA2103923A1 Pmn-derived cr3 modulator and uses thereof |
| 08/05/1992 | CA2101331A1 Factor iia inhibitors |
| 08/04/1992 | US5136027 Method for renaturing proteins in the presence of alkyl sulfate detergents |
| 08/04/1992 | US5136026 Chromatographic ion exchanging; chelating agent, ionic detergents |
| 08/04/1992 | US5136025 Method to purify basic fibroblast growth factor |
| 08/04/1992 | US5136024 Extraction of granulocyte macrophage colony stimulating factor from bacteria |
| 08/04/1992 | US5136023 Genetically engineered; activity of human fibronectin |
| 08/04/1992 | US5136022 Mature polypeptide for monitoring immune systems; immunoassays or nucleic acid hybrid probes; diagnostic tool |
| 08/04/1992 | US5136021 TNF-inhibitory protein and a method of production |
| 08/04/1992 | US5136019 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
| 08/04/1992 | US5135919 Method and a pharmaceutical composition for the inhibition of angiogenesis |
| 08/04/1992 | US5135916 Inhibition of complement mediated inflammatory response |
| 08/04/1992 | US5135912 Natriuretic peptides from the pituitary prohormone proopiomelanocortin |
| 08/04/1992 | US5135868 Cultures of yeast of the genus Pichia altered by site selective genomic modification |
| 08/04/1992 | US5135867 Pesticides, ionsecticides |
| 08/04/1992 | US5135864 Includes lymphadenopathy associated virus; detecting complex formed by retrovirus and antibodies; elisa |
| 08/04/1992 | US5135862 Method of isolating restriction fragment deletions in vibrio cholerae, products thereof |
| 08/04/1992 | US5135856 Culturing African green monkey epithelial cells in low sodium medium |
| 08/04/1992 | US5135736 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 08/04/1992 | CA1305932C Process for the preparation of human antithrombin iii (atiii), vectors and host cells suitable for this purpose, biologically active atiii obtained in this way and medicaments containing the latter |
| 08/04/1992 | CA1305930C Sustained high-level production of recombinant human gamma interferon using a bovine papillomavirus vector |
| 08/04/1992 | CA1305929C Monoclonal antibodies and method for detecting dioxins and dibenzofurans |
| 08/04/1992 | CA1305918C Bacterial antigens, antibodies, vaccines, and methods of manufacture |
| 08/01/1992 | WO1992013954A1 BACILLUS THURINGIENSIS CRYIIIC(b) TOXIN GENE AND PROTEIN TOXIC TO COLEOPTERAN INSECTS |
| 08/01/1992 | WO1992013886A1 Composition of antibodies directed against the humain or animal interleukin-2 receiver |
| 08/01/1992 | CA2101338A1 Bacillus thuringiensis cryiiic(b) toxin gene and protein toxic to coleopteran insects |
| 08/01/1992 | CA2078450A1 Composition of antibodies directed against the human or animal interleukin-2 receiver |
| 07/31/1992 | CA2060235A1 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 07/30/1992 | DE4102594A1 Method of expression of genes under nitrogen deficiency - pref. using the glutamine synthetase promoter 2 of E.coli and ammonium and/or glutamine as limiting nitrogen source |
| 07/29/1992 | WO1992012728A1 Repressors of the trans-activating function of papillomavirus e2 proteins |
| 07/29/1992 | EP0496725A2 Complex containing coagulation factor IX |
| 07/29/1992 | EP0496606A1 Vav proto-oncogene protein |
| 07/29/1992 | EP0496452A1 Novel endothelin receptor antagonists isolated from microbispora |
| 07/29/1992 | EP0496327A1 Polypeptides with prourokinase activity, plasmids coding therefor and process for their preparation and use |
| 07/29/1992 | EP0496174A1 Villin gene promoter sequence and its use in vectors, transformed mammalian cell lines, transgenic animals, and cell lines derived from the animals |
| 07/29/1992 | EP0496162A2 Peptide inhibitors of RAS-GAP interaction |
| 07/29/1992 | EP0496013A1 Synthetic peptide derived from human lipocortin V and use thereof |
| 07/29/1992 | EP0495995A1 Plasmid for use in producing inflamed region derived phospholipase a 2? inhibitory protein, microbial cell, and production and use of said protein |
| 07/29/1992 | EP0495963A1 Improved hypoglycemics |
| 07/29/1992 | EP0495911A1 Non-specific dna amplification |
| 07/29/1992 | EP0495910A1 Production and use of human nm23 protein and antibodies therefor |
| 07/29/1992 | EP0495907A1 cDNA FRAGMENT CODING THE ALPHA INTERFERON RECEPTOR GENE AND PROCESS FOR THE PREPARATION OF A CORRESPONDING PROTEIN |
| 07/29/1992 | EP0495896A1 Vaccines for protecting against infections by hiv virus;process for producing the same and their use as diagnostic and immunotherapy means. |
| 07/29/1992 | EP0495893A1 Dopamine releasing protein |
| 07/29/1992 | EP0495836A1 Dye transfer inhibition. |
| 07/29/1992 | EP0495811A1 Production of genetically-engineered vaccines for aids and other retroviral diseases |
| 07/29/1992 | EP0435996A4 Modified transforming growth factor -g(a) oligopeptides and pharmaceutical compositions thereof |
| 07/29/1992 | EP0396555B1 Purification of monomeric interferon |
| 07/29/1992 | EP0236416B1 Polypeptide production |
| 07/29/1992 | CN1063110A Amedes of antibiotic ge 2270 factors |
| 07/29/1992 | CN1063109A Improvements in and relating to hormones |
| 07/29/1992 | CN1017626B Growth resulating factor for new cell |
| 07/28/1992 | US5134227 DNA encoding immunoreactive, chimeric HTLV-III GAG proteins |
| 07/28/1992 | US5134123 Amino acid derivatives |